Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Tomaculous neuropathy 1Stomach Neoplasms 1Renal Insufficiency, Chronic 1Renal Artery Obstruction 1Pulmonary Embolism 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Neuroma 1Median Neuropathy 1Lung Neoplasms 1Insulin Resistance 1Inflammation 1Head and Neck Neoplasms 1Hand Injuries 1Disease 1Carpal Tunnel Syndrome 1

Interventions

Propofol 6Carboplatin 5Sevoflurane 4Saline Solution 3Paclitaxel 3Nivolumab 3Erlotinib Hydrochloride 3Acetaminophen 3Pemetrexed 2Midazolam 2Lidocaine 2Isoflurane 2Docetaxel 2Desflurane 2Cryotherapy 2Bupivacaine 2Bronchoscopy 2Anesthesia, Inhalation 2trametinib 1sotorasib 1pegfilgrastim 1icotinib 1endostar protein 1durvalumab 1dabrafenib 1capmatinib 1camrelizumab 1beta Carotene 1atezolizumab 1alectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lung Neoplasms × Acetylcysteine × Clear all
NCT02476526 2017-11-28

Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease

VA Greater Los Angeles Healthcare System

Phase 4 Completed
50 enrolled
Thoracic

Lung Neoplasms, Pulmonary Embolism, Renal Artery Obstruction, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡